Log in to save to my catalogue

Huntington Disease: Linking Pathogenesis to the Development of Experimental Therapeutics

Huntington Disease: Linking Pathogenesis to the Development of Experimental Therapeutics

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_1874639045

Huntington Disease: Linking Pathogenesis to the Development of Experimental Therapeutics

About this item

Full title

Huntington Disease: Linking Pathogenesis to the Development of Experimental Therapeutics

Publisher

New York: Springer US

Journal title

Current neurology and neuroscience reports, 2017-02, Vol.17 (2), p.18

Language

English

Formats

Publication information

Publisher

New York: Springer US

More information

Scope and Contents

Contents

Huntington disease (HD) is an autosomal dominant neurodegenerative condition caused by a CAG trinucleotide expansion in the huntingtin gene. At present, the HD field is experiencing exciting times with the assessment for the first time in human subjects of interventions aimed at core disease mechanisms. Out of a portfolio of interventions that clai...

Alternative Titles

Full title

Huntington Disease: Linking Pathogenesis to the Development of Experimental Therapeutics

Authors, Artists and Contributors

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_journals_1874639045

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_1874639045

Other Identifiers

ISSN

1528-4042

E-ISSN

1534-6293

DOI

10.1007/s11910-017-0711-8

How to access this item